Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.

MLA

Liao, Jie, et al. “Inhibition of Mutant KrasG12D-Initiated Murine Pancreatic Carcinoma Growth by a Dual c-Raf and Soluble Epoxide Hydrolase Inhibitor t-CUPM.” Cancer Letters, vol. 371, no. 2, Feb. 2016, pp. 187–93. EBSCOhost, https://doi.org/10.1016/j.canlet.2015.11.042.

APA

Liao, J., Hwang, S. H., Li, H., Yang, Y., Yang, J., Wecksler, A. T., Liu, J.-Y., Hammock, B. D., & Yang, G.-Y. (2016). Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM. Cancer Letters, 371(2), 187–193. https://doi.org/10.1016/j.canlet.2015.11.042

Chicago

Liao, Jie, Sung Hee Hwang, Haonan Li, Yihe Yang, Jun Yang, Aaron T. Wecksler, Jun-Yan Liu, Bruce D. Hammock, and Guang-Yu Yang. 2016. “Inhibition of Mutant KrasG12D-Initiated Murine Pancreatic Carcinoma Growth by a Dual c-Raf and Soluble Epoxide Hydrolase Inhibitor t-CUPM.” Cancer Letters 371 (2): 187–93. doi:10.1016/j.canlet.2015.11.042.